📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-07 10:23
510 analysed today
510
Today
133,399
All-time analysed
40,108
Positive
6,279
Negative
79,197
Neutral
7,747
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
17 announcements match the current filters (relevance ≥ 5).
₹2,300 Cr Capex for Site 5 and Strategic Dow Partnership for Silicones
Aether Industries is executing a massive expansion strategy, headlined by a ₹2,200-₹2,300 Cr investment in its 'Magnum' Site 5, which represents nearly 200% of its TTM revenue. The company is pivoting its revenue mix toward high-margin Contract Exclusive Manufacturing (CEM) and CRAMS, targeting a 70%+ share within two years. A landmark multi-year research partnership with Dow Chemical has been launched to develop silicone manufacturing technologies, marking Aether's entry into a new platform chemistry. Additionally, the company is positioning itself as an upstream supplier for the AI and 5G semiconductor markets through advanced low-dielectric materials.
Confidence: HIGH
What changedAether has transitioned from a specialty chemical manufacturer to a strategic R&D and manufacturing partner for global giants like Dow and Baker Hughes, while entering the semiconductor material supply chain.
Why it mattersThe scale of the ₹2,300 Cr capex relative to the company's current ₹1,153 Cr TTM revenue indicates a massive capacity leap that could significantly re-rate the business if the targeted 1.5-1.75x asset turns are achieved.
Site 5 Total Investment: ₹2,300 CrCapex vs TTM Revenue: 199.4%CEM EBITDA Margin: 28-30%Expected Asset Turn (Site 5): 1.5 to 1.75Target CEM/CRAMS Revenue Mix: 70%+
📅 Short termPositive sentiment expected following the Dow partnership announcement and clear visibility on Site 5 Phase 1 ramp-up.
📈 Long termStructural transformation into a high-end material science company for AI, 5G, and Silicones could sustain high growth for several years.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution risk on large-scale ₹2,300 Cr capex
- High valuation (P/E 95.7)
- Dependency on global tech cycles for AI/5G materials
Key Highlights
Planned investment of ₹2,200 to ₹2,300 Cr for Site 5 (Magnum) featuring 16 production blocks.
Targeting 70%+ revenue contribution from CEM and CRAMS segments in the next 2 years.
CEM segment maintains high EBITDA margins between 28% and 30%.
R&D infrastructure scaling to 160 cumulative fume hoods by FY2028.
Exclusive multi-year research program with Dow Chemical for silicone technology development announced July 30, 2026.
👀 What to Watch
Watch for the execution timeline of Site 5 Phase 2 (FY2030) and the commercialization of the Dow silicone partnership, as these are critical for justifying the current high P/E valuation.
Aether Q1 FY27 PAT at ₹48.4 Cr; Promoters Re-appointed for 5-Year Terms
Aether Industries reported a standalone total comprehensive income of ₹48.38 Cr for Q1 FY27, representing a 20.1% growth compared to ₹40.26 Cr in the same quarter last year. The Board approved the re-appointment of the founding promoter family, including MD Ashwin Desai, for new 5-year terms starting October 2026, ensuring leadership continuity. The company also received a final insurance settlement of ₹26.01 Cr related to a 2023 fire incident. While YoY performance improved, the quarterly EPS of ₹3.64 is slightly lower than the ₹4.07 reported in the immediate preceding quarter (Mar 2026).
Confidence: HIGH
What changedReported Q1 FY27 financial results and secured management continuity for the next five years through promoter re-appointments.
Why it mattersThe earnings growth confirms the company's trajectory in specialty chemicals, while leadership stability is critical for executing its massive 172% R&D capacity expansion plan.
Q1 FY27 PAT (Comprehensive): ₹48.38 CrYoY PAT Growth: 20.1%Insurance Settlement Received: ₹26.01 CrQ1 FY27 EPS: ₹3.64Settlement vs TTM Revenue: ~2.25%
📅 Short termThe stock may see positive sentiment due to YoY earnings growth and the resolution of a major historical insurance claim.
📈 Long termLeadership continuity for 5 years supports the long-term strategy of shifting revenue mix toward high-margin CRAMS and CEM services.
⚠ Risk flags
- High management concentration within the promoter family
- Pending insurance claim for ₹7 Cr inventory loss from March 2026 fire
Key Highlights
Standalone Total Comprehensive Income for Q1 FY27 reached ₹48.38 Cr, up from ₹40.26 Cr YoY.
Basic EPS for the quarter stood at ₹3.64, a 20% increase from ₹3.03 in Q1 FY26.
Final insurance settlement of ₹26.01 Cr received for the November 2023 fire incident at Manufacturing Facility-II.
Re-appointment of 4 promoter-directors for 5-year terms effective October 1, 2026, subject to shareholder approval.
Allotment of 32,752 equity shares under the Employee Stock Option Scheme during the quarter.
👀 What to Watch
Investors should monitor the recovery of the ₹7 Cr insurance claim for the March 2026 warehouse fire and the commissioning timelines for Site-3, 4, and 5 expansions to sustain the 35% growth target.
Aether Partners with Dow India for Silicone Tech; R&D Capacity Expanding 172%
Aether Industries has announced a collaborative research program with Dow Chemical International to develop silicone manufacturing technologies in India. The research and pilot-scale development will be conducted at Aether's Surat facilities, leveraging their ongoing R&D expansion from 55 to 150 fume hoods (a 172% increase). While the immediate contract value is not disclosed, the agreement includes a framework for long-term strategic partnership and potential industrial-scale manufacturing. This collaboration aligns with Aether's goal to increase its CEM and CRAMS revenue mix to 70-75%.
Confidence: HIGH
What changedAether has secured a strategic R&D partnership with global major Dow Chemical, specifically targeting the silicone materials market.
Why it mattersThis validates Aether's technical capabilities in complex chemistry and strengthens its CRAMS pipeline, which is central to its 35% CAGR growth strategy and margin expansion goals.
R&D Capacity Expansion: 172%Target CEM/CRAMS Revenue Mix: 70-75%TTM Revenue: ₹1153 CrMarket Cap: ₹19765 Cr
📅 Short termThe announcement is likely to be viewed positively by the market as it validates Aether's R&D-led business model through a partnership with a global industry leader.
📈 Long termIf successful, this collaboration could lead to significant long-term manufacturing contracts in the silicone space, supporting the company's structural shift toward higher-margin specialty chemicals.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution risk in R&D outcomes
- Lack of immediate disclosed financial value
- Long lead times for commercialization
Key Highlights
Collaborative research program launched with Dow Chemical International for silicone technology.
R&D infrastructure expanding by 172% to 150 fume hoods to support CRAMS and CEM growth.
Targeting a revenue mix of 70-75% from high-margin CEM and CRAMS segments.
Program includes potential for future industrial-scale manufacturing of developed technologies.
Aether reported TTM revenue of ₹1153 Cr and maintains a high OPM of 31.4%.
👀 What to Watch
Watch for the transition of this research program into commercial-scale manufacturing orders, which would provide more visibility on revenue contribution. Monitor the completion timeline of the R&D expansion at the Surat facility.
Aether Partners with Dow India for Silicone Technology Research and Manufacturing Program
Aether Industries has signed a collaborative research agreement with Dow Chemical International to develop indigenous silicone manufacturing technologies in India. The program will be executed at Aether's Surat R&D facility, which is currently undergoing a 172% expansion in fume hood capacity (from 55 to 150). While the immediate contract value is not disclosed, the agreement establishes a framework for long-term strategic partnership and potential industrial-scale manufacturing. This move aligns with Aether's goal to increase its CRAMS and CEM revenue mix to 70-75%.
Confidence: HIGH
What changedAether has secured a strategic research partnership with a global chemical leader (Dow), validating its R&D capabilities.
Why it mattersThis partnership provides a high-margin pipeline for Aether's CRAMS division and positions the company to capture domestic demand in the specialized silicone materials market.
R&D Fume Hood Expansion: 172% (55 to 150)TTM Revenue: ₹1153 CrTarget CRAMS/CEM Revenue Mix: 70-75%Market Cap: ₹19765 Cr
📅 Short termThe announcement is likely to be viewed positively by the market as it validates Aether's technical expertise through association with a global major like Dow.
📈 Long termIf successful, this research collaboration could lead to significant long-term manufacturing orders, supporting Aether's 35% revenue CAGR target.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- R&D execution risk
- No guaranteed timeline for commercialization
- Financial terms of the research phase not disclosed
Key Highlights
Collaborative research program with Dow Chemical International for silicone manufacturing technology.
Research and pilot-scale development to be conducted at Aether's Surat facility.
Aether is expanding R&D infrastructure by 172% (from 55 to 150 fume hoods) to support such programs.
Agreement includes a framework for potential future industrial-scale manufacturing of developed technologies.
Targeting high-growth sectors including construction, mobility, electronics, and healthcare.
👀 What to Watch
Watch for future announcements regarding the transition from pilot-scale research to industrial-scale manufacturing contracts, which would provide more concrete revenue visibility.
Aether Q1 FY27 PAT up 33% to Rs 62.7 Cr; Site 5 Phase One Commences Operations
Aether Industries reported a strong Q1 FY27 with revenue rising 27% YoY to Rs 326.6 Cr and PAT increasing 33% to Rs 62.7 Cr. The company successfully operationalized Site 5 Phase One (2 production blocks) and Site 3++, while onboarding 10 new customers. High-margin CEM and CRAMS segments now contribute 60% of revenue, with a target to reach 70% within two years. R&D investment remains robust at 6.16% of revenue (Rs 19.8 Cr) to fuel future product launches.
Confidence: HIGH
What changedCommercialization of new production blocks at Site 5 and Site 3++, alongside a 10-customer expansion in the client base.
Why it mattersValidates the company's strategy to shift towards higher-margin contract manufacturing and research services, reducing reliance on Large Scale Manufacturing (LSM) and supporting its 35% CAGR target.
Q1 FY27 Revenue: Rs 326.6 CrQ1 Revenue vs TTM Revenue: 28.3%Q1 FY27 PAT: Rs 62.7 CrCEM/CRAMS Revenue Share: 60%R&D Spend: Rs 19.8 Cr
📅 Short termPositive sentiment expected as the company demonstrates strong YoY growth and margin stability at 31% EBITDA despite previous warehouse fire impacts.
📈 Long termStructural growth is supported by massive R&D expansion (targeting 150 fume hoods) and the operationalization of multiple new sites (3, 4, and 5) to capture global specialty chemical demand.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Chinese pricing pressure (potential 10-15% revenue impact)
- High valuation (P/E 90.1) leaves little room for execution delays
- Execution risk in ramping up new production sites
Key Highlights
Revenue from operations grew 27% YoY to Rs 326.6 Cr in Q1 FY27.
Net Profit (PAT) increased 33% YoY to Rs 62.7 Cr, with margins improving to 19%.
CEM and CRAMS segments now contribute 60% of total revenue, targeting 70% by FY29.
Site 5 Phase One (2 production blocks) commenced commercial operations in Q1 FY27.
R&D expenditure for the quarter stood at Rs 19.8 Cr, representing 6.16% of revenue.
👀 What to Watch
Monitor the revenue ramp-up from Site 5 Phase One in Q2 FY27 and the construction progress of the new R&D center (Catalyst/Site-1) expected by Q1 FY28.
Aether Q1 FY27 PAT up 33% to ₹62.7 Cr; Site 5 Phase One Commences Operations
Aether Industries reported a strong Q1 FY27 with revenue growing 27% YoY to ₹326.6 Cr and PAT increasing 33% to ₹62.7 Cr. The growth is primarily driven by a strategic shift towards high-margin CEM and CRAMS segments, which now contribute 60% of total revenue. Operationally, the company successfully commenced commercial production at Site 5 (Phase One) and Site 3++, while onboarding 10 new customers. R&D investment remains robust at 6.16% of revenue, supporting a pipeline focused on Oil & Gas and Material Science segments.
Confidence: HIGH
What changedAether has transitioned from construction to commercial operations at Site 5 and Site 3++, while successfully pivoting its business mix further toward contract manufacturing.
Why it mattersThe operationalization of new sites provides the necessary capacity to sustain the company's 35% CAGR target, while the shift to CEM/CRAMS improves margin profiles and reduces reliance on generic specialty chemicals.
Q1 FY27 Revenue Growth (YoY): 27%Q1 FY27 PAT Growth (YoY): 33%EBITDA Margin: 31%R&D Spend (Q1 FY27): ₹19.8 CrNew Customers Onboarded: 10Revenue vs TTM Revenue: ~28.3%
📅 Short termThe stock is likely to react positively to the strong YoY earnings growth and the successful commissioning of new production blocks at Site 5.
📈 Long termThe structural shift toward a 70% CEM/CRAMS revenue mix and the massive 172% expansion in R&D infrastructure (fume hoods) position the company for high-value growth over the next 2-3 years.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- High P/E valuation (90.1) leaves little room for execution misses
- Dependency on global logistics and potential Chinese competition pricing pressure
- Execution risk in ramping up Site 5 to full capacity
Key Highlights
Revenue from operations increased 27% YoY to ₹326.6 Cr in Q1 FY27
Net Profit (PAT) grew 33% YoY to ₹62.7 Cr with margins improving to 19%
CEM and CRAMS segments now account for 60% of revenue, targeting 70% within two years
Site 5 Phase One (2 production blocks) commenced commercial operations in Q1 FY27
R&D expenditure stood at ₹19.8 Cr, representing 6.16% of quarterly revenue
👀 What to Watch
Monitor the revenue ramp-up from Site 5 starting Q2 FY27 and the execution timeline for the new R&D building (Catalyst/Site-1) expected by Q1 FY28. Investors should also track the progress of CEM contract negotiations across the Oil & Gas and Material Science sectors.
Aether Industries Commences Commercial Operations at Manufacturing Site 5 Phase 1
Aether Industries has officially started commercial operations at its Manufacturing Site 5 located in GIDC Panoli, Gujarat, as of June 26, 2026. The initial operations cover two blocks within the first phase of this new facility, marking a significant step in the company's growth trajectory. This site is strategically positioned to significantly boost the company's production capacity and drive future revenue growth. Investors should view this as a key milestone in the company's long-term expansion strategy.
Key Highlights
Commercial operations commenced at Manufacturing Site 5 (Plot No. 14+15, GIDC Panoli) on June 26, 2026.
The launch includes two specific blocks within the first phase of the site's development.
The facility is expected to be a primary driver for achieving extended production capacities.
Management anticipates this site will contribute significantly to the company's revenue growth in the coming years.
👀 What to Watch
This expansion signals strong execution of growth plans; investors should monitor the ramp-up of this facility and its impact on upcoming quarterly revenue figures.
Aether Industries Receives Final Insurance Claim Settlement for 2023 Fire Accident
Aether Industries Limited has received the final insurance claim settlement on June 5, 2026, for the fire accident that occurred on November 29, 2023. The company stated that this final amount successfully offsets all losses reported from the incident. This concludes a long-standing recovery process involving multiple regulatory updates since late 2023.
Key Highlights
Final insurance claim settlement received on the evening of June 5, 2026.
Settlement pertains to the fire accident reported on November 29, 2023.
The company has successfully managed to offset all losses incurred due to the fire.
This marks the conclusion of a series of updates provided between November 2023 and January 2025.
👀 What to Watch
Investors should view this as a positive development as it removes the financial uncertainty related to the 2023 fire losses. The full recovery of losses strengthens the balance sheet and concludes a significant legacy issue.
Aether Industries: ICRA Reaffirms [ICRA]A+ Rating; Outlook Revised to Stable from Positive
ICRA has reaffirmed Aether Industries' long-term rating at [ICRA]A+ and short-term rating at [ICRA]A1 for bank facilities totaling Rs. 296 crore. While the ratings remain investment grade, the outlook has been revised from 'Positive' to 'Stable' following the review of FY2026 financial results. The facilities include cash credit and letter of credit limits from ICICI Bank, HDFC Bank, and Axis Bank. This adjustment reflects a stabilization of the credit profile rather than the previously anticipated upward trajectory.
Key Highlights
Long-term rating reaffirmed at [ICRA]A+ for Rs. 296 crore bank facilities
Outlook revised from Positive to Stable based on FY2026 financial performance
Short-term rating for non-fund-based limits reaffirmed at [ICRA]A1
Total rated exposure of Rs. 296 crore distributed across ICICI, HDFC, and Axis Bank
Rating action follows the company's annual financial results released on May 15, 2026
👀 What to Watch
The revision to a 'Stable' outlook suggests that immediate rating upgrades are unlikely; investors should focus on the company's ability to maintain margins. No immediate action is required as the core investment-grade rating remains intact.
Aether Industries Q4 FY26: Strong 20% YoY Pricing Growth and Site 4 Revenue Jumps 4x
Aether Industries reported a robust Q4 FY26, characterized by a 20% YoY increase in product pricing and a significant 4x revenue surge from Site 4 to INR 220 crores. The company's business mix is shifting towards higher-margin segments, with CRAMS and CEM now contributing 55% of total revenue. Management has provided a positive outlook with the commissioning of Site 5 and Site 3++, aiming for CRAMS/CEM to exceed 70% of sales in the coming years. Additionally, the company is doubling its R&D capacity by FY28 and expanding its global leadership to target the semiconductor and material science sectors.
Key Highlights
Product pricing increased by 20% YoY and 18% QoQ in Q4 FY26, driven by global supply chain disruptions.
Site 4 revenue grew from INR 50 crores to INR 220 crores, now representing 21% of total sales.
Three new large-scale manufacturing products (2 Pharma, 1 Agro) are set for commissioning by early June 2026 at Site 5.
CRAMS and CEM business models contributed 55% of revenue, with 19 new marquee clients added during the year.
R&D expansion is on track to double current capacity by Q2 FY28, supporting increased inquiries in material sciences.
👀 What to Watch
Investors should focus on the successful ramp-up of Site 5 and the company's ability to maintain high margins as CRAMS projects transition to exclusive manufacturing. The stock remains a high-growth play in the specialized chemical and R&D services space.
Aether Industries Approves FY26 Results; Reports ₹70M Fire Loss and Appoints Europe BD Head
Aether Industries approved its FY26 financial results, which were impacted by a ₹70 million inventory loss due to a fire at an external warehouse in March 2026. The company's subsidiary, Aether Speciality Chemicals, contributed significantly with a revenue of ₹2,199.72 million and a PAT of ₹496.39 million. To bolster international growth, the board appointed Guenter Stevens, a veteran with 40 years of experience, as the Business Development Leader for Europe. Additionally, the company is still resolving an insurance claim from a 2023 fire, with ₹89.68 million currently recognized as a receivable.
Key Highlights
Recognized a ₹70 million inventory loss in Q4 FY26 results due to a warehouse fire on March 11, 2026.
Appointed Guenter Stevens as Business Development Leader – Europe to drive international expansion starting June 2026.
Subsidiary Aether Speciality Chemicals reported FY26 revenue of ₹2,199.72 million and PAT of ₹496.39 million.
Ongoing insurance claim for a 2023 fire incident shows ₹89.68 million still pending as a receivable after receiving ₹210 million.
Consolidated financial results for the year ended March 31, 2026, have been audited and approved by the board.
👀 What to Watch
Investors should monitor the company's safety protocols and insurance recovery progress given the recurring fire incidents. The appointment of a senior leader for Europe is a positive move for long-term growth, but short-term margins may be pressured by the recent inventory loss.
Aether Industries FY26 Revenue Grows 38% to ₹11,601M; PAT Up 39%
Aether Industries reported a strong financial performance for FY26, with consolidated revenue rising 38% to ₹11,601 million and PAT increasing 39% to ₹2,195 million. The growth was largely driven by the Contract Exclusive Manufacturing (CEM) and CRAMS segments, which now contribute over 55% of total revenue. While Q4 FY26 EBITDA was impacted by a ₹70 million inventory loss due to a fire at an external warehouse, overall EBITDA margins for the year improved to 31%. The company is aggressively expanding capacity, with Site 3++ now operational and Site 5 Phase 1 expected to start commercial production in June 2026.
Key Highlights
FY26 Consolidated Revenue grew 38% Y/Y to ₹11,601 million with EBITDA up 53% to ₹3,547 million.
Contract Exclusive Manufacturing (CEM) segment revenue share increased to 46.3% in FY26 compared to 34% in FY25.
Site 5 Phase 1 commercial production is scheduled for June 2026, with Phase 2 expansion already underway.
R&D investment stood at ₹862.13 million in FY26, accounting for 7.3% of total revenues.
The company onboarded 19 new customers across all business models during the financial year.
👀 What to Watch
Investors should focus on the successful ramp-up of Site 3++ and the upcoming Site 5, which are critical for sustaining growth in FY27. The increasing revenue share from high-margin CEM and CRAMS segments is a positive indicator of long-term profitability.
Aether Industries FY26 Results: Appoints Europe BD Head and Reports ₹70M Fire Loss
Aether Industries approved its FY26 audited results, with its subsidiary Aether Speciality Chemicals contributing ₹2,199.72 million in revenue and ₹496.39 million in net profit. The company appointed Guenter Stevens, an industry veteran with 40 years of experience, as Business Development Leader for Europe to spearhead international growth. However, the quarter was impacted by a ₹70 million inventory loss due to a warehouse fire in March 2026. The company is also still resolving a ₹299.68 million asset loss claim from a previous 2023 fire incident, having received ₹210 million thus far.
Key Highlights
Subsidiary Aether Speciality Chemicals reported FY26 revenue of ₹2,199.72 million and PAT of ₹496.39 million.
Recognized a ₹70 million inventory loss in Q4 FY26 results following a warehouse fire on March 11, 2026.
Appointed Guenter Stevens as Business Development Leader – Europe to drive expansion starting June 1, 2026.
Insurance claim for 2023 fire remains open with ₹89.68 million still recognized as a receivable against a total loss of ₹299.68 million.
Board approved audited standalone and consolidated financial results for the year ended March 31, 2026.
👀 What to Watch
Investors should monitor the company's ability to recover the recent ₹70 million fire loss through insurance and evaluate if the new European leadership translates into higher export orders. The recurring nature of fire incidents suggests a need for closer scrutiny of the company's operational risk and safety protocols.
Aether Industries Commences Commercial Operations at Manufacturing Site 3++
Aether Industries has officially commenced commercial operations at its new Manufacturing Site 3++ in Surat, Gujarat, effective February 22, 2026. This facility, located at Plot No. 8202/2/A-B, is designed to significantly boost the company's total production capacity. Management expects this site to be a primary contributor to revenue growth in the coming fiscal periods. The timely operationalization of this site demonstrates the company's ability to execute large-scale infrastructure projects.
Key Highlights
Commercial operations at Manufacturing Site 3++ started on February 22, 2026
Facility is located at Plot No. 8202/2/A-B in Sachin GIDC, Surat
Site is expected to be a key contributor to production capacity and revenue growth
Expansion aligns with the company's long-term strategy to scale specialty chemical manufacturing
👀 What to Watch
Investors should view this as a positive growth catalyst and monitor the facility's utilization levels in upcoming quarterly reports. The expansion supports a long-term growth outlook for the stock as it scales its manufacturing base.
Aether Industries Q3 FY26: PAT Jumps 49% YoY to ₹64.5 Cr; EBITDA Margins Expand to 34%
Aether Industries reported a robust Q3 FY26 with revenue growing 44% YoY to ₹317.1 crore and PAT increasing 49% to ₹64.5 crore. The company achieved significant operational leverage as EBITDA margins expanded to 34% from 28% in the previous year. Strategic diversification is evident as the combined share of Oil & Gas and Material Science rose to 40%, reducing reliance on Pharma and Agro. Management confirmed that Site 3++ and the first two blocks of Site 5 are ready for commercial production, which will drive future volume growth.
Key Highlights
Revenue from operations increased 44% YoY to ₹3,171 million in Q3 FY26.
EBITDA surged 75% YoY to ₹1,083 million with margins improving by 600 bps to 34%.
Site 4 (Baker Hughes) revenue grew 20% QoQ to ₹60 crore, with further scale-up expected in FY27.
Successfully forayed into electronic chemicals for the semiconductor industry with clients in Japan, South Korea, and Taiwan.
Volume growth in large-scale manufacturing exceeded 25% YoY, supported by stable pricing.
👀 What to Watch
Investors should maintain a positive outlook given the strong margin expansion and successful diversification into high-growth sectors like semiconductors and oil & gas. The upcoming commercialization of Site 5 provides a clear catalyst for revenue growth in FY27.
Aether Industries Q3 FY26 PAT Jumps 49% Y/Y to ₹645M; Revenue Up 44%
Aether Industries reported a strong Q3 FY26 with consolidated revenue growing 44% Y/Y to ₹3,171 million, driven by growing CEM contracts and LSM demand. EBITDA rose 75% Y/Y to ₹1,083 million, reflecting significant operating leverage and a shift in segment mix. Net profit (PAT) for the quarter increased 49% Y/Y to ₹645 million, while the 9M FY26 PAT of ₹1,655 million has already exceeded the full-year FY25 figure. The company confirmed that commercial production at Site 5 Phase 1 and Site 3++ is scheduled to begin in March 2026.
Key Highlights
Consolidated Revenue for Q3 FY26 stood at ₹3,171 million, up 44% Y/Y and 13% Q/Q.
EBITDA grew 75% Y/Y to ₹1,083 million with a 9M FY26 EBITDA margin of 31.83%.
Contract/Exclusive Manufacturing (CEM) contribution increased to 43% of revenue in Q3 FY26 from 38% in Q3 FY25.
Site 5 Phase 1 and Site 3++ expansion projects are on track for commercial production by March 2026.
R&D spending for 9M FY26 reached ₹606.09 million, accounting for 7.01% of total revenues.
👀 What to Watch
Investors should note the strong growth in high-margin CEM contracts and the upcoming capacity expansions as key growth catalysts. The fact that 9M FY26 profits have already surpassed full-year FY25 levels indicates a significant earnings breakout.
Aether Industries Q3 FY26 PAT Jumps 48% YoY to ₹64.48 Cr; Revenue Up 44%
Aether Industries reported a strong performance for Q3 FY26, with consolidated revenue from operations growing 44.3% YoY to ₹317.12 crore. Net profit for the quarter rose significantly by 48.6% YoY to ₹64.48 crore, compared to ₹43.39 crore in the same period last year. The 9-month performance also showed robust growth, with PAT reaching ₹165.46 crore against ₹108.12 crore in 9M FY25. However, the company is still assessing the final financial impact of the Q3 FY24 fire incident, which remains an 'Emphasis of Matter' for auditors.
Key Highlights
Revenue from operations increased 44.3% YoY to ₹3,171.21 million in Q3 FY26.
Consolidated Net Profit grew 48.6% YoY to ₹644.79 million from ₹433.90 million.
9M FY26 Revenue reached ₹8,533.58 million, a 42.6% increase over 9M FY25.
Basic EPS improved to ₹4.86 in Q3 FY26 from ₹3.27 in the year-ago quarter.
Exceptional items of ₹23.38 million were recorded due to excess insurance premiums and related costs.
👀 What to Watch
Investors should view the strong revenue and profit growth positively, indicating successful scaling of operations. Monitor the final settlement regarding the fire incident insurance claim, as it remains an unresolved accounting matter that could impact future fixed asset valuations.
